Enter the first few characters of Company and click 'Go'
Annual Financial Results of Jagsonpal Pharmaceuticals Ltd.(Figures in Rs crores)
|
|
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Net Sales / Income |
236.71 |
226.10 |
187.95 |
158.57 |
166.83 |
Other Income |
5.73 |
3.34 |
4.39 |
2.53 |
1.43 |
Net Profit/Loss |
26.72 |
19.59 |
17.06 |
7.87 |
7.22 |
Raw Material |
31.21 |
40.42 |
38.63 |
36.78 |
38.79 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
56.41 |
57.68 |
53.98 |
50.37 |
46.61 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
110.63 |
96.60 |
70.97 |
61.63 |
52.67 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.41 |
0.29 |
0.51 |
0.51 |
0.75 |
Gross Profit |
39.47 |
28.85 |
22.96 |
10.54 |
10.02 |
Depreciation |
1.21 |
1.53 |
1.09 |
1.13 |
1.02 |
Taxation |
8.09 |
7.73 |
4.81 |
1.54 |
1.79 |
Extra Ordinary Item |
-3.46 |
0 |
0 |
0 |
0 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
13.10 |
13.10 |
13.09 |
13.10 |
13.10 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
10.20 |
7.48 |
6.52 |
3 |
2.75 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article